Adial Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $1.5M | $5.5M | $4.4M |
| FY2021 | $4.0M | $7.5M | $6.1M |
| FY2022 | $2.5M | $5.7M | $4.0M |
| FY2023 | $653.1K | $4.7M | $2.8M |
| FY2024 | $975.9K | $5.0M | $3.8M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $1.5M | $5.5M | $4.4M |
| FY2021 | $4.0M | $7.5M | $6.1M |
| FY2022 | $2.5M | $5.7M | $4.0M |
| FY2023 | $653.1K | $4.7M | $2.8M |
| FY2024 | $975.9K | $5.0M | $3.8M |